BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21584184)

  • 1. In silico studies on marine actinomycetes as potential inhibitors for Glioblastoma multiforme.
    Kirubakaran P; Kothapalli R; Singh KhD; Nagamani S; Arjunan S; Muthusamy K
    Bioinformation; 2011 Apr; 6(3):100-6. PubMed ID: 21584184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lycorine inhibits glioblastoma multiforme growth through EGFR suppression.
    Shen J; Zhang T; Cheng Z; Zhu N; Wang H; Lin L; Wang Z; Yi H; Hu M
    J Exp Clin Cancer Res; 2018 Jul; 37(1):157. PubMed ID: 30016965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KZL204, a Trifluoromethylated Quinazoline Derivative, Exhibits High Potent Anti-Tumor Effects on Glioblastoma Multiforme U251MG Cells.
    Huang Y; Yu J; Cheng S; Luo H; Hu X
    Ann Clin Lab Sci; 2023 Nov; 53(6):861-871. PubMed ID: 38182147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
    Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
    J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphA2 as a novel molecular marker and target in glioblastoma multiforme.
    Wykosky J; Gibo DM; Stanton C; Debinski W
    Mol Cancer Res; 2005 Oct; 3(10):541-51. PubMed ID: 16254188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential.
    Stockhausen MT; Kristoffersen K; Stobbe L; Poulsen HS
    Cancer Biol Ther; 2014 Feb; 15(2):216-24. PubMed ID: 24525857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma.
    Gai QJ; Fu Z; He J; Mao M; Yao XX; Qin Y; Lan X; Zhang L; Miao JY; Wang YX; Zhu J; Yang FC; Lu HM; Yan ZX; Chen FL; Shi Y; Ping YF; Cui YH; Zhang X; Liu X; Yao XH; Lv SQ; Bian XW; Wang Y
    Signal Transduct Target Ther; 2022 Feb; 7(1):33. PubMed ID: 35105853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanylate binding protein-1 mediates EGFRvIII and promotes glioblastoma growth in vivo but not in vitro.
    Lan Q; Wang A; Cheng Y; Mukasa A; Ma J; Hong L; Yu S; Sun L; Huang Q; Purow B; Li M
    Oncotarget; 2016 Mar; 7(9):9680-91. PubMed ID: 26848767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel caffeic acid phenethyl ester (CAPE) derivatives and their biological activity studies in glioblastoma multiforme (GBM) cancer cell lines.
    Sucu BO; Koc EB; Savlug Ipek O; Mirat A; Almas F; Guzel MA; Dogan B; Uludag D; Karakas N; Durdagi S; Guzel M
    J Mol Graph Model; 2022 Jun; 113():108160. PubMed ID: 35248814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme.
    Stockhausen MT; Broholm H; Villingshøj M; Kirchhoff M; Gerdes T; Kristoffersen K; Kosteljanetz M; Spang-Thomsen M; Poulsen HS
    Exp Cell Res; 2011 Jul; 317(11):1513-26. PubMed ID: 21514294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dioxinodehydroeckol: A Potential Neuroprotective Marine Compound Identified by In Silico Screening for the Treatment and Management of Multiple Brain Disorders.
    Ahmad F; Sachdeva P; Sachdeva B; Singh G; Soni H; Tandon S; Rafeeq MM; Alam MZ; Baeissa HM; Khalid M
    Mol Biotechnol; 2024 Apr; 66(4):663-686. PubMed ID: 36513873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EGFRvIII variant in glioblastoma multiforme.
    Gan HK; Kaye AH; Luwor RB
    J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens.
    Feldkamp MM; Lala P; Lau N; Roncari L; Guha A
    Neurosurgery; 1999 Dec; 45(6):1442-53. PubMed ID: 10598712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts.
    Johnson H; Del Rosario AM; Bryson BD; Schroeder MA; Sarkaria JN; White FM
    Mol Cell Proteomics; 2012 Dec; 11(12):1724-40. PubMed ID: 22964225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EGFR variant III mutant as a target for immunotherapy of glioblastoma multiforme.
    Chistiakov DA; Chekhonin IV; Chekhonin VP
    Eur J Pharmacol; 2017 Sep; 810():70-82. PubMed ID: 28583430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells.
    Hu J; Jo M; Cavenee WK; Furnari F; VandenBerg SR; Gonias SL
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15984-9. PubMed ID: 21896743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells.
    Sangar V; Funk CC; Kusebauch U; Campbell DS; Moritz RL; Price ND
    Mol Cell Proteomics; 2014 Oct; 13(10):2618-31. PubMed ID: 24997998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of EphA2 Receptor in Angiogenesis Signaling Pathway of Glioblastoma Multiforme.
    Baharuddin WNA; Yusoff AAM; Abdullah JM; Osman ZF; Ahmad F
    Malays J Med Sci; 2018 Nov; 25(6):22-27. PubMed ID: 30914876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
    Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
    Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.